MarginsXMarginsX
Home › Markets › Health Care › HUM

Humana Inc. (HUM)

HUM trades on NYSE in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$461.25
+2.50% on the day
Market cap
$55.4B
Large cap
Revenue · 2025
$129.7B
+10.1% on 2024
Net income · 2025
$1.2B
0.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/49071/000004907126000009/0000049071-26-000009-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerHUM on NYSE
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000049071
SEC industry codeHospital & Medical Service Plans
Incorporated inDE

Financials · 2025

LineValue
Revenue$129.7B
Net income$1.2B
Operating income$2.7B
Net margin0.9%
Operating margin2.1%
Revenue growth+10.1%
Cash$4.2B
Total assets$48.9B
P/E (computed)46.6×
P/S (computed)0.4×

Warning signs

Cash runway
Cash-flow positive
$6.9B cash at September 30, 2026
Share count, 1 year
-0.1%
2025-09-30 to 2026-09-30 · -2.4% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
$150K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$6.9B cash; operating cash flow $932.8M a quarter.Report 2026-09-30
Shares outstanding120,103,250 (2026-09-30); 120,273,068 a year earlier; 123,110,720 three years earlier.Cover page 2026-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedownsLatest 2026-03-06
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Louisville, Kentucky, United StatesPCAOB Form AP 2026-03-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $150K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$41.2B$162.0M$2.2B$6.9B$12.5B$154.2B10-Q 2026-11-06
Q2 2026
2026-06-30
$40.9B$694.0M$2.0B$6.9B$14.2B$145.7B10-Q 2026-07-29
Q1 2026
2026-03-31
$39.6B$1.2B$1.3B$5.0B$14.0B$137.2B10-Q 2026-04-29
Q4 2025
2025-12-31
$32.5B-$796.0M-$1.7B$4.2B$12.4B$129.7B10-K 2026-02-19
Q3 2025
2025-09-30
$32.6B$195.0M$971.0M$5.4B$12.6B$126.4B10-Q 2026-11-06
Q2 2025
2025-06-30
$32.4B$545.0M$1.3B$4.0B$12.6B$123.1B10-Q 2026-07-29
Q1 2025
2025-03-31
$32.1B$1.2B$331.0M$4.3B$13.3B$120.3B10-Q 2026-04-29
Q4 2024
2024-12-31
$29.2B-$693.0M-$528.0M$2.2B$11.7B$117.8B10-K 2026-02-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-03-06
Latest annual report10-K2026-02-19
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-09
Latest proxyDEFA14A2026-03-06

Source: SEC EDGAR submissions feed, 1,011 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.7%
1 month+7.0%
3 months+16.9%
Year to date+75.7%
1 year+90.1%
From 52-week high0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
NTRANatera Inc.$288.48-9.59%$41.8B
CIThe Cigna Group$300.16+1.06%$79.1B
CNCCentene Corporation$74.77+4.91%$37.0B
ELVElevance Health Inc.$446.28+3.86%$96.4B
LHLabcorp Holdings Inc.$372.46+0.53%$30.2B
ILMNIllumina Inc.$198.00-4.35%$29.9B
DGXQuest Diagnostics Incorporated$262.21+1.01%$28.8B
GHGuardant Health Inc.$144.03-5.06%$19.5B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier